TY - GEN
T1 - The Formation of p-Methoxycinnamic Acid-Caffeine Co-Crystal by the Solution Evaporation Method and its Physicochemical Characterization
AU - Setyawan, Dwi
AU - Sulistyowaty, Melanny Ika
AU - Sari, Intan Purnama
AU - Yusuf, Helmy
AU - Zaini, Erizal
N1 - Publisher Copyright:
© 2023 American Institute of Physics Inc.. All rights reserved.
PY - 2023/5/19
Y1 - 2023/5/19
N2 - P-Methoxycinnamic acid (PMCA) was an anti-inflammatory agent owing mechanism of action by inhibiting cyclooxygenase enzyme thus disrupted the conversion of arachidonic acid to prostaglandin. Unfortunately, PMCA had poor solubility in water. This affected the bioavailability of the compound in the blood which giving low efficacy. To improve its solubility, the formation co-crystal of PMCA with caffeine was carried out at a molar ratio 1:1 using the solvent evaporation method. Co-crystal was characterized by several methods, such as Differential Scanning Calorimetry (DSC), Powder X-Ray Diffraction (PXRD), Scanning Electron Microscope (SEM), and also Fourier Transform Infrared (FTIR). According to the thermograms, diffractograms, microphotographs, and IR spectra of APMS-caffeine co-crystal had different physicochemical characteristics compared to its physical mixture and also starting materials. The DSC thermogram showed the melting point of co-crystal was 155.09°C. While diffractogram of co-crystal exhibited some new peaks at 9.4054°, 13.8609°, 15.2124°, 17.8274° and 19.2285° of 2θ value. Furthermore, microphotograph of co-crystal showed a columnar crystal habit. It was the different crystal form from the crystal habit of each starting materials, PMCA and caffeine. The IR spectra displayed some changes of absorption bands in the O-H and C=O function groups of the PMCA which indicates hydrogen bonding with caffeine.
AB - P-Methoxycinnamic acid (PMCA) was an anti-inflammatory agent owing mechanism of action by inhibiting cyclooxygenase enzyme thus disrupted the conversion of arachidonic acid to prostaglandin. Unfortunately, PMCA had poor solubility in water. This affected the bioavailability of the compound in the blood which giving low efficacy. To improve its solubility, the formation co-crystal of PMCA with caffeine was carried out at a molar ratio 1:1 using the solvent evaporation method. Co-crystal was characterized by several methods, such as Differential Scanning Calorimetry (DSC), Powder X-Ray Diffraction (PXRD), Scanning Electron Microscope (SEM), and also Fourier Transform Infrared (FTIR). According to the thermograms, diffractograms, microphotographs, and IR spectra of APMS-caffeine co-crystal had different physicochemical characteristics compared to its physical mixture and also starting materials. The DSC thermogram showed the melting point of co-crystal was 155.09°C. While diffractogram of co-crystal exhibited some new peaks at 9.4054°, 13.8609°, 15.2124°, 17.8274° and 19.2285° of 2θ value. Furthermore, microphotograph of co-crystal showed a columnar crystal habit. It was the different crystal form from the crystal habit of each starting materials, PMCA and caffeine. The IR spectra displayed some changes of absorption bands in the O-H and C=O function groups of the PMCA which indicates hydrogen bonding with caffeine.
KW - Caffeine
KW - Co-crystal
KW - Physicochemical Characterization
KW - Solvent Evaporation
KW - p-Methoxycinnamic acid
UR - http://www.scopus.com/inward/record.url?scp=85161395699&partnerID=8YFLogxK
U2 - 10.1063/5.0119975
DO - 10.1063/5.0119975
M3 - Conference contribution
AN - SCOPUS:85161395699
T3 - AIP Conference Proceedings
BT - Proceedings of the International Conference on Advanced Technology and Multidiscipline, ICATAM 2021
A2 - Widiyanti, Prihartini
A2 - Jiwanti, Prastika Krisma
A2 - Prihandana, Gunawan Setia
A2 - Ningrum, Ratih Ardiati
A2 - Prastio, Rizki Putra
A2 - Setiadi, Herlambang
A2 - Rizki, Intan Nurul
PB - American Institute of Physics Inc.
T2 - 1st International Conference on Advanced Technology and Multidiscipline: Advanced Technology and Multidisciplinary Prospective Towards Bright Future, ICATAM 2021
Y2 - 13 October 2021 through 14 October 2021
ER -